FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s

The Food and Drug Administration (FDA) connected Tuesday sent 30 telehealth companies informing letters astir their “illegal” income of compounded GLP-1s, gathering disconnected expanding unit to tamp down connected the merchantability of these unapproved medications. According to the FDA, the companies they contacted made “false oregon misleading claims” astir the GLP-1 products they sold on…